updated Sun. August 18, 2024
-
Facts of Week
April 3, 2018
The Gadolinium Market report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the market. In this report, the Gadolinium market valuein 2017 and expected value to by the end of 2022 and growth rate between 2017 and 2022 isÃâà...
P&T Community
April 3, 2018
Older patients, those with hypertension, and those with more bright spots on their brain scans (associated with brain aging) were more likely to show gadolinium in the vitreous chamber at 24 hours. In a minority of patients, both eye chambers showed gadolinium at two hours. In those patients, stroke tended to affect a largerÃâà...
New York Times
March 28, 2018
Because the positron moves so quickly through the water, it emits the optical equivalent of a sonic boom, called Cherenkov radiation. (Watchman is a shortening of Water Cherenkov Monitor of Antineutrinos.) Mixed in the water will be the element gadolinium, which will absorb the neutron generated in theÃâà...
Business Services
March 27, 2018
Gadolinium-based Contrast Media Market size is anticipated to see significant growth prospects from 2018 to 2022. The objective of Gadolinium-based Contrast Media market report is to provide a detailed analysis of Gadolinium-based Contrast Media industry and its impact based on applications and onÃâà...
Investor Opinion
March 15, 2018
Gadolinium(III) Oxide Market report 2023 focuses on the major Types and Applications for the key players. Gadolinium(III) Oxide market research report also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gadolinium(III) Oxide marketÃâà...
Radiology Business
March 13, 2018
The use of gadolinium-based contrast agents (GBCAs) in MRI brain studies was long thought to be safe for patients without severe renal insufficiency, but in 2014, researchers started finding evidence that GBCAs can leave traces of gadolinium (GD) behind in the brain. Interest in the subject has increased,Ãâà...
Health Imaging
March 12, 2018
“Although the link between [gadolinium-based contrast agents] GBCA deposition and dentate T1 shortening is now well established, the clinical significance of intracranial GD accumulation, if any, remains unknown,” wrote corresponding author Vikas Agarwal, MD, with the department of radiology at theÃâà...
Health Imaging
March 12, 2018
A worldwide study, published in Current Problems in Diagnostic Radiology, revealed wide inconsistencies in reporting brain gadolinium deposition (GD) based on a lack of understanding and an effort to minimize anxiety in patients. “Although the link between [gadolinium-based contrast agents] GBCAÃâà...
Business Services
March 9, 2018
Gadolinium Market Report cover detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. The Gadolinium market report provides an in-depth overview of Product Specification, technology, product type and production analysisÃâà...
Medical Physics Web
March 5, 2018
What if gadolinium-based contrast agents (GBCAs) could be used at just 10% of current dose levels without significantly degrading image quality or contrast enhancement? Artificial intelligence (AI) could make that possible, according to research published in the Journal of Magnetic Resonance Imaging (J.
Cardiovascular Business
March 2, 2018
Cardiac magnetic resonance (CMR) stress T1 mapping outperformed gadolinium-based first-pass perfusion imaging in a head-to-head comparison, detecting obstructive CAD with a 0.97 area under the curve (AUC) versus a 0.91 AUC. Obstructive CAD was defined by fractional flow reserve (FFR) less thanÃâà...
Korea Biomedical Review
February 28, 2018
The Ministry of Food and Drug Safety said it would revise the warning labels for eight types of gadolinium-based contrast agents (GBCAs), encompassing a total of 25 such products. The label changes will go into effect on Mar. 15. “Our ministry examined the safety information of GBCAs by comprehensivelyÃâà...
Korea Biomedical Review
February 27, 2018
Gadobutrol is a Gadolinium-based contrast agent used in diagnostic MRIs in adults and children to highlight areas in the central nervous system that have disrupted blood-brain barriers (BBB) or abnormal vascularity. It also works to expose the presence of breast disease, and detect stroke and tumorÃâà...
Health Data Management
February 27, 2018
Most patients suspected of having a stroke are given an MRI, typically with a contrasting agent such as gadolinium. Gadolinium is a harmless, transparent chemical; it remains in the blood stream and is filtered out by the kidneys in healthy people. But a stroke disrupts the blood-brain barrier, enabling theÃâà...
The Lund Report
December 31, 1999
Other studies since then have confirmed small amounts of gadolinium are retained in certain brain tissues in amounts roughly proportional to gadolinium exposure. One research team published a survey of people with self-reported symptoms and called it “gadolinium deposit disease.” In November, GenaÃâà...
The Truth Today
December 31, 1999
The Gadolinium-based Contrast Media Market Report covers the insightful data for business strategists, Growth Prospects and historical & futuristic cost and revenue over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers theÃâà...
Phys.Org
December 31, 1999
The initial test subjected a sample of gadolinium to sequential magnetic fields, causing the sample to alternate between heating up and cooling down. Using precisely timed pumps to circulate water during those heating and cooling cycles, the system demonstrated sustained cooling power of about 10Ãâà...
|
news and opinion
|